Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

THE TRUTH ABOUT: Huma - Caught on Camera

Humacyte Q1 Earnings Call Highlights

Humacyte (NASDAQ:HUMA) reported first-quarter 2026 Symvess sales of $0.5 million and outlined a series of commercial, clinical and cost-reduction initiatives aimed at accelerating adoption of its bioengineered vascular products. On the company’s earnings call, President and Chief Executive Officer

MarketBeat · May 13

Microchip Technology, Tesla, Humacyte And Other Big Stocks Moving Higher On Tuesday

Microchip Technology, Tesla, Humacyte And Other Big Stocks Moving Higher On Tuesday

U.S. stocks were mixed, with the Dow Jones index falling over 100 points on Tuesday.

Benzinga · Jul 8, 2025

Huma Joins the Global Dollar Network to Advance Stablecoin Adoption on Solana

Huma Joins the Global Dollar Network to Advance Stablecoin Adoption on Solana

San Francisco, California, June 4th, 2025, Chainwire

International Business Times · Jun 4, 2025

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

This Surging Small-Cap Biotech Has One Very High-Profile Investor

Humacyte is a pre-revenue biotech company that has delivered outsized gains to shareholders in 2024. But is the small-cap stock a good buy right now?

Barchart · Jun 3, 2024

The ultimate gel taste test: We sampled 21 energy gels so you don't have to

We undertook a comprehensive tasting of the commonly available energy gels, and did our best to find something nice to say about each of them.

Cycling Weekly · Apr 1, 2024

Humacyte's Return On Capital Employed Insights

Pulled from Benzinga Pro data, Humacyte (NASDAQ:HUMA) posted Q4 earnings of $42.59 million, an increase from Q3 of 234.92%. Sales dropped to $177.00 thousand, a 26.56% decrease between quarters.

Benzinga · Mar 30, 2022

Humacyte's Human Acellular Vessel Shows Long Term Benefit In Hemodialysis Patients

Humacyte Inc (NASDAQ: HUMA)

Benzinga · Feb 28, 2022

inkl

Read news from The Economist, FT, and more,
with one subscription

Humacyte Posts Preclinical Data Of Small-Diameter Human Acellular Vessel In Bypass Grafting

Humacyte Posts Preclinical Data Of Small-Diameter Human Acellular Vessel In Bypass Grafting

Humacyte Inc (NASDAQ: HUMA) has announced

Benzinga · Jan 28, 2022

1

Coverage From

People

Tommy Tuberville

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Microchip Technology

Quiver Quantitative

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play